메뉴 건너뛰기




Volumn 24, Issue 11, 2001, Pages 1219-1230

Basic and therapeutic relevance of endothelina-mediated regulation

Author keywords

Cardiovascular remodeling; Endothelin; Heart failure; Hypertension; Receptor antagonist; Renal failure

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ABT 147627; ATRASENTAN; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOSPORIN; DARUSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; GROWTH FACTOR; LOSARTAN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PED 3512; PLACEBO; RO 46 0203; SITAXSENTAN; TACROLIMUS; TAK 044; TBC 1125; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE AGENT;

EID: 0035167669     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.24.1219     Document Type: Article
Times cited : (31)

References (211)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.